Summary
- Current Price
- As of today, ARQT price is $26.46, down -0.30% on
- Current Price All-Time High
- ARQT price is currently -35.27% below its historical high of $40.88 set on
- Market Cap
- ARQT current market cap is $3B, up +75.82% over the past 365 days
- PE Ratio
- ARQT current PE ratio is 127.76
- Revenue
- ARQT current annual revenue is $376.07M, up +91.34% year-over-year
- Next Earnings
- The next earnings release for ARQT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Arcutis Biotherapeutics, Inc. |
| Ticker | NASDAQ: ARQT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | arcutis.com |
| Employees | 342 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $26.46 | |
| Price, 1D Change | -0.30% | |
| $3B | ||
| - | ||
| 127.76 | ||
| 1.14 | ||
| $376.07M | ||
| Revenue, 1Y Change | +91.34% | |
| -$0.13 | ||
| EPS, 1Y Change | +89.04% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$0.13 | ||
| EPS Estimate | $0.41 | N/A |
| EPS Est. Change | +424.43% | N/A |
| $376.07M | ||
| Revenue Estimate | $536.95M | N/A |
| Revenue Est. Change | +42.78% | N/A |
| Current Price | $26.46 | |
| Price Target | $37.00 | - |
| Price Tgt. Change | +39.83% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.34 | -$1.16 | +13.60% | |
| -$0.14 | -$0.13 | +7.44% | |
| $0.41 | N/A | +424.43% | |
| $1.30 | N/A | +1,127.03% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $185.49M | $196.54M | +5.96% | |
| $360.31M | $376.07M | +4.37% | |
| $536.95M | N/A | +42.78% | |
| $685.52M | N/A | +82.28% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $26.46 | |
| $25.60 | ||
| $26.62 | ||
| $24.05 | ||
| $26.11 | ||
| -$0.16 | ||
| 1.14 | ||
| $1.13 | ||
| 49.78 | ||
| 39.21% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $376.07M | ||
| -$0.13 | ||
| $339.38M | ||
| 90.24% | ||
| -$12.23M | ||
| -3.25% | ||
| -$16.14M | ||
| -4.29% | ||
| -$6.86M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.60 | ||
| 3.17 | ||
| 2.99 | ||
| - | ||
| 7 | ||
| 6.07 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 127.76 | ||
| 7.17 | ||
| 15.08 | ||
| 86.04 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $189.48M | ||
| $221.29M | ||
| $432.97M | ||
| $411.23M | ||
| $243.49M | ||
| $129.84M | ||
| $114.23M | ||
| $1.00M | ||
| $12.53M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $392.21M | ||
| $351.60M | ||
| $36.70M | ||
| $0.00 | ||
| $4.67M | ||
| $0.00 | ||
| $1.17M |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$5.63M | ||
| -$30.25M | ||
| $6.97M | ||
| $10.69M | ||
| -$16.31M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Needham | → | |
| Morgan Stanley | → | |
| Guggenheim | → | |
| Needham | → | |
| Mizuho | → | |
| Guggenheim | → | |
| TD Cowen | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Needham | → |
Analyst sentiment
Institutional ownership
No data
Screeners with ARQT
FAQ
- What is the ticker symbol for Arcutis Biotherapeutics, Inc.?
- The ticker symbol for Arcutis Biotherapeutics, Inc. is NASDAQ:ARQT
- Does Arcutis Biotherapeutics, Inc. pay dividends?
- No, Arcutis Biotherapeutics, Inc. does not pay dividends
- What sector is Arcutis Biotherapeutics, Inc. in?
- Arcutis Biotherapeutics, Inc. is in the Healthcare sector
- What industry is Arcutis Biotherapeutics, Inc. in?
- Arcutis Biotherapeutics, Inc. is in the Biotechnology industry
- What country is Arcutis Biotherapeutics, Inc. based in?
- Arcutis Biotherapeutics, Inc. is headquartered in United States
- When did Arcutis Biotherapeutics, Inc. go public?
- Arcutis Biotherapeutics, Inc. initial public offering (IPO) was on January 31, 2020
- Is Arcutis Biotherapeutics, Inc. in the S&P 500?
- No, Arcutis Biotherapeutics, Inc. is not included in the S&P 500 index
- Is Arcutis Biotherapeutics, Inc. in the NASDAQ 100?
- No, Arcutis Biotherapeutics, Inc. is not included in the NASDAQ 100 index
- Is Arcutis Biotherapeutics, Inc. in the Dow Jones?
- No, Arcutis Biotherapeutics, Inc. is not included in the Dow Jones index
- When was Arcutis Biotherapeutics, Inc. last earnings report?
- Arcutis Biotherapeutics, Inc.'s most recent earnings report was on August 5, 2026
- When does Arcutis Biotherapeutics, Inc. report earnings?
- The next expected earnings date for Arcutis Biotherapeutics, Inc. is October 27, 2026
Data Sources & References
- ARQT Official Website www.arcutis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1787306/000178730626000018/0001787306-26-000018-index.htm
- ARQT Profile on Yahoo Finance finance.yahoo.com/quote/ARQT
- ARQT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arqt